Sterling Capital Management LLC Biotechnology

Sterling Capital Management LLC

$7.04 Trillion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
EWTX Edgewise Therapeutics, Inc.	$970M	$2.24 Million 0.0% of portfolio	171	Q2 2025 Added 128.0%
ARDX Ardelyx, Inc.	$816M	$2.15 Million 0.0% of portfolio	548	Q2 2025 Added 114.06%
GERN Geron Corp	$521M	$2.07 Million 0.0% of portfolio	1,467	Q2 2025 Reduced 58.56%
ABSI Absci Corp	$320M	$2.03 Million 0.0% of portfolio	789	Q2 2025 Added 81.8%
CRMD Cor Medix Inc.	$459M	$1.91 Million 0.0% of portfolio	155	Q2 2025 Added 3.33%
AVXL Anavex Life Sciences Corp.	$712M	$1.86 Million 0.0% of portfolio	202	Q2 2025 Reduced 79.24%
LQDA Liquidia Corp	$1.44B	$1.84 Million 0.0% of portfolio	148	Q2 2025 Added 111.43%
CDXC Chroma Dex Corp.	$420M	$1.82 Million 0.0% of portfolio	126	Q2 2025 Added 152.0%
LIFE A Tyr Pharma Inc	$53.2M	$1.8 Million 0.0% of portfolio	355	Q2 2025 New
MDXG Mimedx Group, Inc.	$765M	$1.75 Million 0.0% of portfolio	286	Q2 2025 Reduced 74.82%
RZLT Rezolute, Inc.	$356M	$1.73 Million 0.0% of portfolio	388	Q2 2025 New
VRNA Verona Pharma PLC	$6.51B	$1.7 Million 0.0% of portfolio	18	Q1 2025 New
XERS Xeris Biopharma Holdings, Inc.	$1.14B	$1.69 Million 0.0% of portfolio	362	Q2 2025 Added 154.93%
ABUS Arbutus Biopharma Corp	$673M	$1.69 Million 0.0% of portfolio	547	Q2 2025 Added 68.83%
CHRS Coherus Bio Sciences, Inc.	$129M	$1.68 Million 0.0% of portfolio	2,294	Q2 2025 Added 52.22%
IMNM Immunome Inc.	$150M	$1.67 Million 0.0% of portfolio	180	Q2 2025 Added 143.24%
ALDX Aldeyra Therapeutics, Inc.	$323M	$1.46 Million 0.0% of portfolio	380	Q2 2025 Reduced 51.09%
CELC Celcuity Inc.	$732M	$1.42 Million 0.0% of portfolio	106	Q2 2025 Added 58.21%
CDXS Codexis, Inc.	$165M	$1.38 Million 0.0% of portfolio	567	Q2 2025 Reduced 54.35%
KMPH Kempharm, Inc	$170M	$1.15 Million 0.0% of portfolio	131	Q2 2025 Reduced 73.21%
STOK Stoke Therapeutics, Inc.	$978M	$1.12 Million 0.0% of portfolio	99	Q2 2025 Added 167.57%
KALV Kal Vista Pharmaceuticals, Inc.	$292M	$1.03 Million 0.0% of portfolio	91	Q2 2025 Added 121.95%
TRVI Trevi Therapeutics, Inc.	$571M	$1 Million 0.0% of portfolio	183	Q2 2025 Reduced 66.97%
FHTX Foghorn Therapeutics Inc.	$189M	$978,000 0.0% of portfolio	208	Q2 2025 Added 10.64%
TSHA Taysha Gene Therapies, Inc.	$222M	$942,000 0.0% of portfolio	408	Q2 2025 Added 147.27%
CAPR Capricor Therapeutics, Inc.	$180M	$923,000 0.0% of portfolio	93	Q2 2025 Reduced 29.55%
ABEO Abeona Therapeutics Inc.	$32.2M	$920,000 0.0% of portfolio	162	Q2 2025 New
ETON Eton Pharmaceuticals, Inc.	$507M	$884,000 0.0% of portfolio	62	Q2 2025 New
OMER Omeros Corp	$277M	$879,000 0.0% of portfolio	293	Q2 2025 Reduced 55.34%
PGEN Precigen, Inc.	$689M	$855,000 0.0% of portfolio	602	Q2 2025 Reduced 72.01%
CADL Candel Therapeutics, Inc.	$160M	$820,000 0.0% of portfolio	162	Q2 2025 Added 295.12%
ALT Altimmune, Inc.	$193M	$724,000 0.0% of portfolio	187	Q2 2025 Reduced 68.78%
SVRA Savara Inc	$400M	$698,000 0.0% of portfolio	306	Q2 2025 Reduced 43.33%
GBIO Generation Bio Co.	$368M	$624,000 0.0% of portfolio	1,949	Q2 2025 Reduced 30.47%
GOSS Gossamer Bio, Inc.	$233M	$565,000 0.0% of portfolio	459	Q2 2025 New
CRVS Corvus Pharmaceuticals, Inc.	$341M	$508,000 0.0% of portfolio	127	Q2 2025 New
SLS Sellas Life Sciences Group, Inc.	$38.4M	$506,000 0.0% of portfolio	231	Q2 2025 New
ADCT Adc Therapeutics Sa	$309M	$469,000 0.0% of portfolio	175	Q2 2025 Reduced 70.69%
YMAB Y M Abs Therapeutics, Inc.	$376M	$392,000 0.0% of portfolio	87	Q2 2025 Added 128.95%
SCPH Sc Pharmaceuticals Inc.	$155M	$351,000 0.0% of portfolio	92	Q2 2025 Added 217.24%
DMAC Dia Medica Therapeutics Inc.	$186M	$250,000 0.0% of portfolio	64	Q2 2025 New
PLX Protalix Bio Therapeutics, Inc.	$120M	$249,000 0.0% of portfolio	168	Q2 2025 New
NVCT Nuvectis Pharma, Inc.	$88.1M	$232,000 0.0% of portfolio	31	Q2 2025 New
GLSI Greenwich Life Sciences, Inc.	$141M	$127,000 0.0% of portfolio	14	Q2 2025 Added 133.33%
INMB Inmune Bio, Inc.	$38.2M	$74,000 0.0% of portfolio	32	Q2 2025 Added 146.15%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sterling Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sterling Capital Management LLC with notifications on news.